Silicon Laboratories (NASDAQ:SLAB) Posts Quarterly Earnings Results, Meets Estimates

Silicon Laboratories (NASDAQ:SLAB) released its quarterly earnings results on Tuesday. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11), RTT News reports. The business had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The business’s revenue was up 91.4% on a year-over-year basis. During the same period last year, the business earned ($1.19) EPS. Silicon Laboratories updated its Q1 2025 guidance to -0.190-0.010 EPS and its Q1 guidance to $(0.19)-0.01 EPS.

Silicon Laboratories Trading Up 4.1 %

NASDAQ:SLAB opened at $142.21 on Wednesday. The firm has a market capitalization of $4.61 billion, a price-to-earnings ratio of -19.29 and a beta of 1.16. The business’s fifty day moving average price is $127.54 and its 200 day moving average price is $116.52. Silicon Laboratories has a 1-year low of $94.00 and a 1-year high of $154.91.

Insider Buying and Selling at Silicon Laboratories

In other news, Director William G. Bock sold 2,000 shares of the company’s stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the completion of the transaction, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. This represents a 5.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.72% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Needham & Company LLC lifted their price objective on Silicon Laboratories from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday. Morgan Stanley cut their price target on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Barclays increased their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Friday, January 17th. JPMorgan Chase & Co. reduced their price target on shares of Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a report on Tuesday, November 5th. Finally, Stifel Nicolaus lifted their price target on Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $136.20.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.